IP Library Granted Patent US 9,951,056
Granted Patent B2
US 9,951,056 · App. 15/025,654 · Granted Apr 24, 2018

Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease

Inventors: Xiangyang Chen (Shanghai, CN); Yingxiang Gao (Shanghai, CN); Chong Liu (Shanghai, CN); Haihong Ni (Shanghai, CN); Mark Mulvihill (Waltham, MA)
Assignee: BEIJING INNOCARE PHARMA TECH CO., LTD.
C07D417/04C07D211/34C07D213/82C07D231/14C07D277/56C07D295/185C07D401/04C07D401/12C07D401/14C07D403/04C07D413/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,951,056
App. No.
15/025,654
Granted
Apr 24, 2018
Kind
B2
Abstract

Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).

Claims (24)

1. A compound selected from the group consisting of: 5-(1-acryloylpiperidin-4-yl)-4′-phenoxybiphenyl-2-carboxamide; and 5-(4-acryloylpiperazin-1-yl)-4′-phenoxybiphenyl-2-carboxamide; or a pharmaceutically acceptable salt or solvate thereof

5-(1-acryloylpiperidin-4-yl)-4′-phenoxybiphenyl-2-carboxamide

5-(4-acryloylpiperazin-1-yl)-4′-phenoxybiphenyl-2-carboxamide.

2. A compound of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide;

or a pharmaceutically acceptable salt or solvate thereof

6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide.

3. A compound selected from the group consisting of:

6-(4-acryloylpiperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide;

6-(4-acryloylpiperazin-1-yl)-2-(4-(3-fluorophenoxy)phenyl)nicotinamide;

6-(4-acryloylpiperazin-1-yl)-2-(3-fluoro-4-phenoxyphenyl)nicotinamide;

6-(4-acryloylpiperazin-1-yl)-2-(4-(2-fluorophenoxy)phenyl)nicotinamide; and

6-(4-acryloylpiperazin-1-yl)-2-(2-fluoro-4-phenoxyphenyl)nicotinamide;

or a pharmaceutically acceptable salt or solvate thereof

6-(4-acryloylpiperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide;

6-(4-acryloylpiperazin-1-yl)-2-(4-(3-fluorophenoxy)phenyl)nicotinamide

6-(4-acryloylpiperazin-1-yl)-2-(3-fluoro-4-phenoxyphenyl)nicotinamide

6-(4-acryloylpiperazin-1-yl)-2-(4-(2-fluorophenoxy)phenyl)nicotinamide

6-(4-acryloylpiperazin-1-yl)-2-(2-fluoro-4-phenoxyphenyl)nicotinamide.

4. A compound selected from the group consisting of:

2-(4-phenoxyphenyl)-6-(4-(vinylsulfonyl)piperazin-1-yl)nicotinamide; and

2-(4-phenoxyphenyl)-6-(1-(vinylsulfonyl)piperidin-4-yl)nicotinamide;

or a pharmaceutically acceptable salt or solvate thereof

2-(4-phenoxyphenyl)-6-(4-(vinylsulfonyl)piperazin-1-yl)nicotinamide

2-(4-phenoxyphenyl)-6-(1-(vinylsulfonyl)piperidin-4-yl)nicotinamide.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2018
From: BEIJING INNOCARE PHARMA TECH CO., LTD.
To: GUANGZHOU INNOCARE PHARMA TECH CO., LTD.
Reel/Frame 046931/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2017
From: X-RX, INC.
To: SHANGHAI BIODURO BIOLOGICS CO., LTD.
Reel/Frame 044949/0746 →
CHANGE OF NAME Recorded Apr 19, 2017
From: BEIJING SYNERCARE PHARMA TECH CO., LTD.
To: BEIJING INNOCARE PHARMA TECH CO., LTD.
Reel/Frame 042094/0531 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: CHEN, XIANGYANG; GAO, YINGXIANG; LIU, CHONG; NI, HAIHONG; MULVIHILL, MARK
To: X-RX, INC.
Reel/Frame 038124/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: X-RX, INC.
To: SHANGHAI BIODURO BIOLOGICALS CO., LTD
Reel/Frame 038124/0970 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: SHANGHAI BIODURO BIOLOGICALS CO., LTD
To: BEIJING SYNERCARE PHARMA TECH CO., LTD.
Reel/Frame 038291/0611 →
Priority Claims (1)
CN 2013 1 0485048 · Oct 16, 2013 · national
Continuity (2)
Provisional Application 61884958 · Sep 30, 2013
Related Publication 20160237075A1 · Aug 18, 2016